SCHEMBL5333741

SCHEMBL5333741

OCCC/C=C/c1nn(Cc2ccc(F)cc2Cl)c2cc(OC(F)(F)F)ccc12

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
F2RL3 Q96RI0 8/20 0.37
ENPP2 Q13822 1/20 0.36
NR1H2 P55055 2/20 0.36
NR1H3 Q13133 2/20 0.36
NR1I2 O75469 1/20 0.36
NR3C1 P04150 1/20 0.36
AR P10275 1/20 0.36
RXRA P19793 1/20 0.36
PPM1A P35813 1/20 0.36
CYP1A2 P05177 2/20 0.35
CYP3A4 P08684 2/20 0.35
CYP2C9 P11712 2/20 0.35
CYP2D6 P10635 1/20 0.35
MAPT P10636 1/20 0.34
TP53 P04637 2/20 0.33
GRM2 Q14416 1/20 0.33
P2RX7 Q99572 1/20 0.33
SCN5A Q14524 1/20 0.33
SCN9A Q15858 1/20 0.33
SLC16A3 O15427 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5333744 1.00 F2RL3 (0.37) F2RL3ENPP2NR1H2NR1H3NR1I2
SCHEMBL5378191 0.95 F2RL3 (0.38) F2RL3ENPP2NR1H2NR1H3NR1I2
SCHEMBL5378187 0.95 F2RL3 (0.38) F2RL3ENPP2NR1H2NR1H3NR1I2
SCHEMBL5359999 0.92 NPSR1 (0.38) F2RL3ENPP2CYP1A2CYP3A4CYP2C9
SCHEMBL5359991 0.92 NPSR1 (0.38) F2RL3ENPP2CYP1A2CYP3A4CYP2C9
SCHEMBL5349786 0.91 F2RL3 (0.42) F2RL3ENPP2PPM1ASCN5ASCN9A
SCHEMBL5349782 0.91 F2RL3 (0.42) F2RL3ENPP2PPM1ASCN5ASCN9A
SCHEMBL5337864 0.88 ENPP2 (0.38) F2RL3ENPP2NR1H2NR1H3CYP2C9
SCHEMBL5337868 0.88 ENPP2 (0.38) F2RL3ENPP2NR1H2NR1H3CYP2C9
SCHEMBL5319914 0.86 NR1H2 (0.39) ENPP2NR1H2NR1H3NR1I2NR3C1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1786424-A2 LONIDAMINE ANALOGUES AND THEIR USE IN MALE CONTRACEPTION AND CANCER TREATMENT The University of Kansas (US) 2007-05-23 EP claimed
WO-2006023704-A2 LONIDAMINE ANALOGUES AND THEIR USE IN MALE CONTRACEPTION AND CANCER TREATMENT UNIVERSITY OF KANSAS (US) 2006-03-02 WO claimed